Navigation Links
Spectros Corporation Signs Distribution Agreements in Middle East
Date:12/6/2011

PORTOLA VALLEY, Calif., Dec. 6, 2011 /PRNewswire/ -- Spectros Corporation announced today an expansion of its distribution channels in the Middle East with the signing of distributors based in the UAE, with expansion to other areas of the Middle East under discussion. These groups will join other distributors already selling Spectros products outside of the U.S.

"We are excited by this continued expansion," noted Director of Sales Elizabeth van Thillo-Rohlff. "More and more physicians are recognizing the opportunity offered by the superior Spectros T-Stat® tissue oximeter, as was confirmed in recent independent studies."

Spectros T-Stat Oximeter is currently the only broadband tissue oximeter on the market in the U.S. and Europe. T-Stat competes in the marketplace with INVOS® oximeters marketed by Covidien, and FORE-SIGHT® oximeters marketed by CAS Medical. In reconstructive surgery, T-Stat competes with oximeters marketed by ViOptix.

An expanded array of probes, including broadband infrared Continuum® monitor, Ceres™ cerebral probes, and multi-site T-Stat monitors are currently in testing, pending FDA approval and release anticipated over the next year.

About Spectros

Spectros markets and licenses advanced molecular sensing and imaging devices that shed light on ischemia and cancer. The company's champion product, the T-Stat Tissue Oximeter, is the first medical device FDA-approved as sensitive to ischemia, an insufficient supply of oxygen to tissue.  T-Stat is the only commercially-available tissue oximeter that utilizes state-of-the-art broadband visible light spectroscopy (VLS). The non-invasive T-Stat system is used clinically to provide a continuous and real-time absolute value, utilizing 260 wavelengths, over the competing oximeter product lines that only use 2-4.

Spectros also develops molecular diagnostic tools for breast and prostate cancer, currently in phase I/II clinical trials supported by the National Cancer Institute.  Spectros is a venture-supported private concern and markets its products in the U.S. and internationally.

(Note:  Forward-looking statements are intended as a guide only, and do not constitute an offer for investment nor a guarantee of future events or returns.  Certain Spectros applications described above have not been reviewed and approved by the FDA, and are therefore labeled "for investigational use only." T-Stat, Continuum, and CereS are trademarks of the Spectros Corporation. INVOS is a trademark of Somanetics and Covidien. FORE-SIGHT is a trademark of CAS Medical).

For further information, visit www.spectros.com.


'/>"/>
SOURCE Spectros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Spectros Signs New International Distribution Deals
2. Spectros Signs New International Distribution Deals
3. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
4. Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
5. CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
8. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
9. delSECUR CORPORATION Announces Agreement to Purchase the Intellectual Property Assets of the Corporation
10. M2SYS Biometric Software Solution Selected By GHG Corporation
11. Harris Corporation Adds Broadband Satellite Data Mode to JTRS-Approved Falcon III(R) AN/PRC-117G Multiband Manpack Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... York, NY (PRWEB) , ... October 12, 2017 ... ... Academy of Sciences today announced the three Winners and six Finalists of the ... are given annually by the Blavatnik Family Foundation and administered by the New ...
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its national board ... Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced ... for membership in ARCS Alumni Hall of Fame . ASTER Labs is ...
Breaking Biology Technology: